Primary Site >> Colorectal Cancer
Gene >> TRG
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Effects of radiotherapy on different histopathological types of rectal carcinoma. PMID: 16630231 Ref: A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation. PMID: 17047490 |
Ref: Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy. PMID: 17278216 |
Ref: Tumour regression grading in patients with residual rectal cancer after preoperative chemoradiation. PMID: 20430458 |
Ref: Oxaliplatin plus dual inhibition of thymidilate synthase during preoperative pelvic radiotherapy for locally advanced rectal carcinoma: long-term outcome. PMID: 20472346 |
Ref: A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. PMID: 22172905 Ref: A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer. PMID: 22212406 Ref: Computed tomography with histological correlation for evaluating tumor regression of rectal carcinoma after preoperative chemoradiation therapy. PMID: 22497951 |
Ref: Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation. PMID: 24023496 Ref: Tumor regression grading of gastrointestinal carcinomas after neoadjuvant treatment. PMID: 24109590 |
Ref: Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. PMID: 24300971 Ref: PDCD4 as a predictor of sensitivity to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients. PMID: 24568503 Ref: Prospective analysis of 18F-FDG PET/CT predictive value in patients with low rectal cancer treated with neoadjuvant chemoradiotherapy and conservative surgery. PMID: 24877151 Ref: Identifying the most predictive post-chemoradiation TRG system for rectal cancer. PMID: 25249541 Ref: Carcinoembryonic antigen half-life is an early predictor of therapeutic effects in induction chemotherapy for liver metastases from colorectal cancer. PMID: 25275051 Ref: Baseline neutrophil-lymphocyte ratio (>/=2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation. PMID: 25518933 |
Ref: Pathologic evaluation of the response of mesorectal positive nodes to preoperative chemoradiotherapy in patients with rectal cancer. PMID: 25724092 Ref: RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trial. PMID: 25888548 Ref: Comparison of the pathological response of the mesorectal positive nodes between short-course chemoradiotherapy with delayed surgery and long-course chemoradiotherapy in patients with rectal cancer. PMID: 26206348 Ref: Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer. PMID: 26269765 Ref: Extramural depth of rectal cancer tumor invasion at thin-section MRI: predicting treatment response to neoadjuvant chemoradiation. PMID: 26309163 Ref: New tumor regression grade for rectal cancer after neoadjuvant therapy and radical surgery. PMID: 26540466 Ref: Combined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer. PMID: 26753066 |
Ref: What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy? PMID: 26511803 Ref: Pathological Assessment of the AJCC Tumor Regression Grading System After Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer. PMID: 26817863 Ref: Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management. PMID: 27255100 Ref: GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer. PMID: 27634904 Ref: [Assessment of the risk factors relating to lymph node metastasis in rectal cancer after neoadjuvant chemoradiotherapy and the clinical significance]. PMID: 27680075 Ref: Neutrophil to Lymphocyte Ratio (NLR) and Derived Neutrophil to Lymphocyte Ratio (d-NLR) Predict Non-Responders and Postoperative Complications in Patients Undergoing Radical Surgery After Neo-Adjuvant Radio-Chemotherapy for Rectal Adenocarcinoma. PMID: 27740855 |
Ref: Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer. PMID: 27271749 Ref: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy. PMID: 28103579 Ref: [Value of functional magnetic resonance imaging in predicting outcomes of neoadjuvant chemoradiotherapy in rectal cancer]. PMID: 28534322 Ref: [Predictive value of serum carcinoembryonic antigen level in efficacy and prognosis for patients with rectal cancer following preoperative radiochemotherapy]. PMID: 28534328 Ref: Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer. PMID: 28583790 Ref: Relationship Between Expression of Proteins ERCC1, ERCC2, and XRCC1 and Clinical Outcomes in Patients with Rectal Cancer Treated with FOLFOX-Based Preoperative Chemoradiotherapy. PMID: 28608017 Ref: Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer. PMID: 28934761 Ref: Young Vs Old Colorectal Cancer in Indian Subcontinent: a Tertiary Care Center Experience. PMID: 29203979 Ref: p21 does, but p53 does not predict pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer. PMID: 29332339 Ref: Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer. PMID: 29383117 |
Ref: Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy. PMID: 28918544 Ref: Phase I and II trial on infusional 5-fluorouracil and gefitinib in combination with preoperative radiotherapy in rectal cancer: 10-years median follow-up. PMID: 29928702 Ref: Tumor regression grade as a clinically useful outcome predictor in patients with rectal cancer after preoperative chemoradiotherapy. PMID: 30314723 Ref: Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer? PMID: 30359275 |